Statera Biopharma (STAB) Competitors

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

$0.0007

0.00 (0.00%)

(As of 09:30 AM ET)

Stock Analysis Chart Competitors Financials Headlines SEC Filings Social Media

STAB vs. SCPS, NOVN, NOVNQ, CALA, HGEN, VRAYQ, AHPI, IGNY, ONCSQ, and CNTX

Should you be buying Statera Biopharma stock or one of its competitors? The main competitors of Statera Biopharma include Scopus BioPharma (SCPS), Novan (NOVN), NVN Liquidation (NOVNQ), Calithera Biosciences (CALA), Humanigen (HGEN), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Ignyte Acquisition (IGNY), OncoSec Medical (ONCSQ), and Context Therapeutics (CNTX). These companies are all part of the "medical" sector.

Statera Biopharma vs.

Scopus BioPharma (NASDAQ:SCPS) and Statera Biopharma (NASDAQ:STAB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, community ranking, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scopus BioPharma
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Statera Biopharma
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, Statera Biopharma had 1 more articles in the media than Scopus BioPharma. MarketBeat recorded 1 mentions for Statera Biopharma and 0 mentions for Scopus BioPharma. Statera Biopharma's average media sentiment score of 0.00 beat Scopus BioPharma's score of -1.57 indicating that Scopus BioPharma is being referred to more favorably in the media.
Company Overall Sentiment
Scopus BioPharma Neutral
Statera Biopharma Very Negative
: Scopus BioPharma has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Comparatively, Statera Biopharma has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.
: Scopus BioPharma received 2 more outperform votes than Statera Biopharma when rated by MarketBeat users.
Company Underperform Outperform
Scopus BioPharma Outperform Votes
2
100.00%
Underperform Votes
No Votes
Statera Biopharma N/A N/A
: Scopus BioPharma has higher earnings, but lower revenue than Statera Biopharma.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Scopus BioPharma N/A N/A -$11.61M N/A N/A
Statera Biopharma $1.49M 0.03 -$101.85M N/A N/A
: Company Net Margins Return on Equity Return on Assets
Scopus BioPharma N/A N/A N/A
Statera Biopharma N/A N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scopus BioPharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Statera Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
Scopus BioPharma	Neutral
Statera Biopharma	Very Negative

Company	Underperform	Outperform
Scopus BioPharma	Outperform Votes 2 100.00%	Underperform Votes No Votes
Statera Biopharma	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scopus BioPharma	N/A	N/A	-$11.61M	N/A	N/A
Statera Biopharma	$1.49M	0.03	-$101.85M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Scopus BioPharma	N/A	N/A	N/A
Statera Biopharma	N/A	N/A	N/A

Summary

Scopus BioPharma and Statera Biopharma tied by winning 3 of the 6 factors compared between the two stocks.

Ad InvestorPlace

Proof that the Musk/Bezos rivalry is about to hit a new level

Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…

Go here now for full story.

Get Statera Biopharma News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

STAB vs. The Competition

Export to Excel

Metric	Statera Biopharma	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$38,000.00	$6.68B	$5.02B	$7.78B
Dividend Yield	N/A	2.76%	2.85%	3.96%
P/E Ratio	N/A	25.01	170.94	19.01
Price / Sales	0.03	258.57	2,376.24	81.32
Price / Cash	N/A	20.25	33.56	28.61
Price / Book	N/A	5.76	5.29	4.59
Net Income	-$101.85M	$139.78M	$105.29M	$217.41M
7 Day Performance	N/A	0.72%	0.63%	1.38%
1 Month Performance	N/A	-4.36%	-3.36%	-2.31%
1 Year Performance	N/A	-1.74%	3.86%	9.83%

Statera Biopharma Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SCPS Scopus BioPharma	0 of 5 stars	$0.00 flat	N/A	-95.8%	$46,000.00	N/A	0.00	13	High Trading Volume
NOVN Novan	0 of 5 stars	$0.00 flat	N/A	N/A	$22,000.00	$24.71M	0.00	90	Analyst Forecast
NOVNQ NVN Liquidation	0 of 5 stars	$0.00 flat	N/A	N/A	$22,000.00	$23.68M	0.00	90
CALA Calithera Biosciences	0 of 5 stars	$0.02 flat	N/A	-54.4%	$97,000.00	$9.75M	0.00	8	Analyst Forecast News Coverage
HGEN Humanigen	0 of 5 stars	$0.00 flat	N/A	N/A	$24,000.00	$1.70M	0.00	6	Gap Up
VRAYQ ViewRay	0 of 5 stars	N/A	N/A	N/A	$18,000.00	$102.21M	0.00	295	Gap Down
AHPI Allied Healthcare Products	0 of 5 stars	N/A	N/A	N/A	$16,000.00	$27.05M	0.00	189	Analyst Forecast
IGNY Ignyte Acquisition	0 of 5 stars	$0.01 flat	N/A	-98.5%	$62,000.00	N/A	0.00	N/A
ONCSQ OncoSec Medical	0 of 5 stars	$0.00 flat	N/A	N/A	$2,000.00	N/A	0.00	40
CNTX Context Therapeutics	1.7347 of 5 stars	$1.33 -2.9%	$4.00 +200.8%	+199.2%	$0.00	N/A	-0.89	5	News Coverage Gap Down

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:STAB) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Statera Biopharma (STAB) Competitors

STAB vs. SCPS, NOVN, NOVNQ, CALA, HGEN, VRAYQ, AHPI, IGNY, ONCSQ, and CNTX

Statera Biopharma vs.

Summary

New MarketBeat Followers Over Time

STAB vs. The Competition

Statera Biopharma Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info